ReviewThe oncologist2025

Current landscape in first-line treatment of metastatic hormone sensitive prostate cancer: a cost-effectiveness focused review.

Cristóbal Ávila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.